Emblem Corp EMMBF

Is the 70k KG plan still a goal?

[daryan1]

Are they still expecting to actually grow 70,000kg at some point or did they revise that

[deminimis]

They haven’t come out and said it but recent statements in their MD&A seem indicate that they are bscking away from that number a bit. I always thought that number was unrealistic. I think they will probably closer to 45-50k. It is somewhat irrelevant though because as I posted on another board: Their main source of revenue won’t be from selling their own grow, it will be from selling

[tarnoir]

IR should be able to help answer this, no? Oh, I forgot, they don't respond to calls/emails etc. This uncertainty adds vulnerablity to a weak stock in a space that's also correcting.

[daryan1]

Appreciate the response. I have another question. I'm hearing words like "pharmaceutical drugs" and "biotech" and "pre-clinical", but I want to clarify, is Emblem actually going to conduct an actual drug Pipeline for their drugs, and go through North American FDA approval process a la Inmed, Tetra bio Etc.? Or are they simply talking about whole-plant based

[deminimis]

I would read this and draw your own conclusions: https://www.baystreet.ca/stockstowatch/2299/Emblem-Positioned-to-be-Disruptive-in-the-Medical-Cannabis-Industry

[daryan1]

Like I said... vague. There's a big difference between secondary medical marijuana products vs clinically tested and monitored prescription pharmaceutical drugs. Which is more likely to be prescribed by a doctor, for example? Although Emblem could very well make products that are able to compete with opioids, what are they going to do to compete with companies like Inmed who are already

[gkmackdadzzz1]

This post has been removed in accordance with Community Policy